Acumetis

Sales & Marketing

Kevin Asher leads Acumetis's Medical Practice, bringing 15+ years in Medical Affairs to teams across the industry.

News

The FDA has cleared Eisai and Biogen's Leqembi Iqlik subcutaneous injection as a starting dose, removing the need for regular infusion clinic visits.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.